CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,937,000 | – | 350,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
| ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
| AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
| Platform Technology Partners | 60,000 | $75,000 | 0.04% |
| PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
| HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
| Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
| Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
| Aries Wealth Management | 23,400 | $33,000 | 0.02% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |